Provider Segment Analysis: Hospitals (Largest Segment) vs Cancer Centers (Fastest-Growing Segment)

Hospitals held the largest share of 67.31% in 2026 in the cancer treatment facilities market, reflecting their broad infrastructure, multidisciplinary capabilities, and ability to provide comprehensive cancer care within established healthcare systems. Hospitals can coordinate diagnosis, surgery, medical treatment, imaging, supportive care, and follow-up services, making them important treatment destinations for patients with varied clinical requirements. Their access to specialized personnel and integrated healthcare resources also supports complex treatment pathways. Increasing demand for coordinated cancer management is reinforcing the importance of facilities capable of addressing multiple stages of care. This broad service capacity provides hospitals with a strong foundation for maintaining their leading position.

Cancer centers are emerging as the fastest-growing provider segment as cancer care increasingly emphasizes specialized treatment environments and dedicated oncology expertise. Specialized centers can organize clinical services, diagnostic capabilities, and treatment resources around cancer-specific patient needs, supporting more focused care pathways. Growing interest in specialized treatment and coordinated oncology services is encouraging patients and healthcare systems to consider dedicated cancer facilities alongside general hospitals. Advances in treatment approaches are also increasing the importance of environments equipped to support specialized oncology practices. This concentration of expertise and infrastructure is strengthening the growth potential of cancer centers.

Treatment Segment Analysis: Cancer Surgery (Largest Segment) vs Chemotherapy (Fastest-Growing Segment)

The cancer surgery segment accounted for the largest share of 36.17% in 2026, reflecting the continued importance of surgical intervention in the management of cancers where removal of tumors or affected tissue is clinically appropriate. Surgical treatment remains an important component of comprehensive cancer care and is often integrated with diagnostic assessment and other treatment modalities. Advances in surgical techniques and improvements in perioperative care are supporting greater precision and treatment effectiveness. The ability of specialized healthcare facilities to coordinate surgical procedures with complementary oncology services further reinforces demand. As cancer care continues to evolve toward multidisciplinary treatment pathways, surgery remains a central treatment category.

Chemotherapy is the fastest-growing treatment segment as systemic cancer treatment continues to play an important role across different stages and types of cancer. Chemotherapy can be used as a primary treatment or alongside surgery and other therapeutic approaches, providing flexibility within broader treatment strategies. Increasing emphasis on comprehensive cancer management is encouraging the integration of systemic therapies into coordinated care pathways. Continued development of treatment protocols and greater focus on individualized cancer management are also supporting the role of chemotherapy. Its ability to complement other treatment approaches is contributing to stronger adoption momentum within cancer treatment facilities.